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S32 IgA Nephropathy81.9 11.5 mmHg; baseline 24-hour urine protein was 1.7 2.2 gram; base-
line serum creatinine was 108.9 60.1 umol/l. 44 patients had microhaema-
turia. 46 of the 50 patients with IgA nephropathy were treated with ACEI/
ARB therapy. 25 out of the 46 patients were given additional steroid therapy
and 8 out of the 25 received a second immunosuppressive agent in the light
of the clinicopathological pictures. The changes in proteinuria and serum
creatinine level at 6 months and 12 months will be reported.
Conclusion: The high prevalence of IgA nephropathy in our biopsy popula-
tion was similar to reports from other regions of mainland China. Besides
ACEI and ARB, steroid and additional immunosuppressant are important
therapies for selected patients with biopsy-proven IgA nephropathy.http://dx.doi.org/10.1016/j.hkjn.2015.08.089
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Objective: Urinary sediment miRNAs have a lot of advantages, such as non-
invasive, simple and easy to get. They may become a new direction of
searching non-invasive biomarkers of IgAN.
Methods: A total 93 IgAN patients, 40 primary glomerulonephritis (non-IgAN)
patients and 92 healthy controls of urinary sediment were collected. Total
miRNAs were extracted and analyzed by miRNA microarray. Urine erythro-
cytes were separated by CD235a magnetic bead and microvesicles were
collected by ultracentrifugation to detect differential miRNAs sources.
Results: Comparing IgAN group with normal control group, we found 214
miRNAs were significantly different by using miRNA chips. By using quantita-
tive PCR, we confirmed that urinary sediment miR-25, miR-144 and miR-486
in IgAN group were significantly higher than these in normal group and dis-
ease control group. ROC curve analysis showed these three miRNAs had
good specificity and sensitivity for the diagnosis of IgAN, in which the AUC
value of miR-486 was the largest and reaching 0.935 (Table 1). By using
CD235a immunomagnetic technology, we confirmed miR-25, miR-144 and
miR-486 were mainly derived from urinary erythrocytes. Moreover, the
increased of miRNAs expression levels in IgAN patients were associated
with erythrocytes passing through IgAN lesions renal glomerulus. When pe-
ripheral blood erythrocytes were compressed when exiting an impaired
nephron, they could secrete some miRNA-containing microparticles.Table 1 The feature of the receiver operating characteristic curve of
miRNAs for diagnosing IgAN.
AUC 95% CI P
value
Optimal
cut-off
value
Sensitivity
(%)
Specificity
(%)
miRNA-
25
0.884 0.831e
0.937
<0.001 2- D D
ct Z 0.045
87.1 79.4
miRNA-
144
0.869 0.811e
0.927
<0.001 2- D D
ct Z 0.006
82.3 77.5
miRNA-
486
0.935 0.897e
0.973
<0.001 2- D D
ct
93.5 85.3Conclusion: Urinary sediment miR-25, miR-144 and miR-486 were good non-
invasive diagnosis biomarkers of IgA nephropathy. They were mainly derived
from erythrocytes. The increase of miRNA expression levels of urinary eryth-
rocytes was associated with erythrocytes passing through IgAN lesions renal
glomerulus. And they may have some biological effects on renal inherent
cells by the release of microvesicles.http://dx.doi.org/10.1016/j.hkjn.2015.08.0900079
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Objective: To investigate the effect of suppressor of cytokine signaling 3
(SOCS3) gene on the proliferation of human glomerular mesangial cells
(HMCs) stimulated by aIgA1 from patients with IgA nephropathy (IgAN),
and explore whether this effect is mediated through Toll like receptor 4
(TLR4) or Transforming growth factor-b1 (TGF-b1).
Methods: Serum monomeric IgA1 was isolated with jacalin affinity and
Sephacryl S- 200 HR chromatography from IgAN patients, and then heated
to aggregated form (aIgA1). HMC was transfected with Adv-SOCS3-IRES2-
EGFP for 48 hours, and incubated with aIgA1 subsequently. The cells were
divided into blank control group, IgA1 group, IgA1+ Adv-EGFP group and
IgA1+ Adv-SOCS3-IRES2–EGFP group. We observed mesangial cell prolifera-
tion through MTT, and detected the levels of SOCS3, TLR4, TGF-b1 protein
and mRNA through western blotting and Real-time PCR.
Results: HMC proliferation was promoted significantly after aIgA1 stimula-
tion, and the strongest effect of promoting cell proliferation was observed
at 0.5 mg/ml concentration after 48h stimulation. Comparing IgA1 group
with control group, the protein and mRNA expression of SOCS3, TLR4,
TGF-b1 were significantly increased in IgA1 group (p < 0.05). Comparing
with IgA1 group and IgA1+Adv-EGFP group, MTT absorbency was obviously
reduced after incubation with aIgA1 for 24h and 48h in IgA+Adv-SOCS3-
EGFP group, and the protein and mRNA expression of TLR4 and TGF-b1
were significantly decreased in IgA1+Adv-SOCS3-EGFP group (p < 0.05).
Conclusion: The stimulation of aIgA1 from IgAN patients promoted HMC prolif-
eration, also upregulated the expression of SOCS3, TLR4 and TGF-b1 in HMC.
Overexpression of SOCS3 may inhibit the proliferation of HMC which stimulated
by aIgA1, partly through down-regulating the expression of TLR4 and TGF-b1.http://dx.doi.org/10.1016/j.hkjn.2015.08.091
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Background: The role of transcription factors SRF, which regulate CArG
element contained genes, in IgA nephropathy is unknown.
Methods: Here we performed expression of SRF in human IgA nephropathy
tissues from I to V stage and the cultured proximal tubular cells (HK-2) under
hypoxia or induced by TGF-b compared with control conditions.
Results: We performed SRF expression from formalin-fixed, paraffin-embedded
tissues from renal biopsies diagnosis as IgA nephropathy. We noted the greatest
change in SRF expression, whichwas significantly higher in IgAV stage compared
with early presenters, like IgA I or II stage. Furthermore, in individual biopsies,
high expression of SRF correlated with tubulointerstitial fibrosis and low esti-
mated GFR. Next, in vitro, we identified overexpression of SRF was observed in
hypoxia-inducedHK-2cells. Treatment ofHK-2withTGF-b increased SRFexpres-
sion. Lower expression of SRF suppressed expression of the CArG element snail1,
thereby opposing TGF-b-mediated downregulation of E-cadherin.
Conclusion: High expression of SRF associates with increased fibrosis and
decreased estimated GFR in IgA nephropathy in vivo, perhaps by
IgA Nephropathy S33enhancing TGF-b-mediated downregulation of snail and E-cadherin in HK-
2.http://dx.doi.org/10.1016/j.hkjn.2015.08.092
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Objective: Currently, diagnosis of IgA nephropathy (IgAN) relies on renal bi-
opsy. Most IgAN is progressive, however, renal biopsy cannot be done
frequently for its invasive property. This study is to investigate non-invasive
protein biomarkers of IgAN from urine supernatant.
Methods: Urine supernatant was collected from 15 IgAN patients (Lee’s
grade I-II, III and IV-V, 5 in each group), 12 none-IgAN glomerular disease con-
trol (DC) patients (MCD, MN and FSGS, 4 in each group) and 5 normal control
(NC). Urine sample were analyzed by Raybiotech protein array for searching
differential expression of protein biomarkers. Candidate protein biomarkers
were further validated in urine samples from other subjects, including 49
IgAN patients (Lee’s grade I-II 8, grade III 31 and grade IV-V 10), 28 DC pa-
tients (MCD 8, MN 8 and FSGS 12) and 14 NC by ELISA method.
Results: Angiostatinwas found differential expressed between IgAN group and
control groups by protein array. By ELISA verification, the level of angiostatin
was significantly higher in IgAN group than NC group (255.15 288.43 vs
3.31 5.96), but lower than DC group, including MN (579.47 211.69 ng/ml)
and MCD (664.56 375.95 ng/ml). Angiostatin showed a significant positive
correlation with SCr (rZ 0.939), BUN (rZ 0.931), Cys C (rZ 0.923), protein-
uria (r Z 0.784), global sclerosis (r Z 0.718) and crescentformation
(rZ 0.588). There was a negative correlation between angiostatin level and
eGFR (rZ0.721). Angiostatin level in IgAN Lee’s grade IV-V groupwas signif-
icantly higher than gradeI-II and grade III group (620.43 271.47 vs
107.38 83.37 vs 117.89 143.84 ng/ml, p < 0.01). The level of angiostatin
was significantly higher in IgAN group with endothelial cell proliferation
change than those without (406.95 336.56 vs 189.41 234.70, p < 0.01).
Conclusion: Urine supernatant angiostatin could be used as a candidate
biomarker for diagnosis of IgAN. Angiostatin level reflects the clinical and
pathological features of IgAN.http://dx.doi.org/10.1016/j.hkjn.2015.08.093
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Objective: Most of IgA nephropathy (IgAN) is chronic progressive glomerulo-
nephritis, with different clinical and pathological features. Evaluation of the
disease by repeated renal biopsy is not practical due to its invasive proce-
dure. Urinary sediment miRNAs are hopeful to serve as non-invasive bio-
markers to assess kidney injury of IgAN.
Methods: 52 biopsy-proven IgAN patients and 25 healthy controls were
enrolled in this study. Urinary sediment miRNAs were extracted. Expressions
of miR-34a, miR-205, miR-21, miR-146a and miR-155 were quantified by
qPCR. ROC (receiver operating characteristic curve) was used to investigate
the value of the miRNAs for predicting dignosis of IgAN and evaluating histo-
pathological injury. The patients were treated according to the KDIGO guide-
line and followed up. The roles of miRNAs in reflecting theraputic efficacy
and disease progression were analyzed.
Results: (1) The IgAN group had significantly lower urinary miR-34a, miR-205,
miR-155 but higher miR-21 levels than controls. Logistic regression analysis
showed that urinary miR-34a0.047, miR-2050.209 and miR-210.461were independent factors for diagnosis of IgAN. The ROC revealed that miR-
2050.125 and miR-210.891 can distinguish IgAN patients with moderate
and severe tubular atrophy and interstitial fibrosis from those with mild
tubular atrophy and interstitial fibrosis. (2) After 21.17 months follow-up,
the level of proteinuria reduction (g/24h/month) was positively correlated
with baseline urinary miR-21 and inversely correlated with miR-205. The sub-
jectswho achieved a complete remission (CR) hadhigher baseline urinarymiR-
205, and lower miR-21 than those without achieveing a CR.
Conclusion: The levels of some urinary sediment miRNAs, especially baseline
miR-21 and miR-205 may be used as prognostic markers for evaluating the
tubulointerstitial damage of IgAN. What’s more, baseline levels of urinary miR-
NAs may be predictors to reflect theraputic efficacy and disease progression.http://dx.doi.org/10.1016/j.hkjn.2015.08.094
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Objective: Mesangial deposition of aberrantly glycosylated IgA1 (agIgA1) and its
immune complex is an initial and key pathogenicmechanism in IgA nephropathy
(IgAN). The present study tested the hypothesis that bacteria-derived IgA prote-
asesmaybeabletodegrade thecirculatinganddepositedagIgA1and its immune
complex locally in the mesangium and may represent a novel therapy for IgAN.
Methods:Wefirst identified bacterial IgA proteases with high enzymatic activ-
ity by screening 14 different bacterial strains (6 species totally). Among them,
4 IgA proteases were selected and their ability to degrade agIgA1 and its im-
mune complex was determined in vitro with artificially deglycosylated IgA1
or human IgAN biopsy and in vivo in a modified mouse model of passive IgAN.
Results: Selected bacteria-derived IgA proteases were capable of degrading
serum agIgA1 and normal IgA1 pretreated with neuraminidase and b-galacto-
sidase in vitro and also the deposited immune complex within the mesangium
of renal biopsy from IgAN patients. In a modified mouse model of passive IgAN
with abundant in situ mesangial deposition of the agIgA-IgG immune complex
in glomeruli, a single intravenous injection of bacterial IgA protease was able
to effectively degrade the deposited immune complex within the glomerulus.
Conclusion: The bacteria-derived IgA protease is a biologically active
enzyme that can specifically degrade serum agIgA systemically and the
deposited agIgA-IgG immune complex locally. Thus, the use of IgA protease
may represent a novel therapy for IgAN.http://dx.doi.org/10.1016/j.hkjn.2015.08.095
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